Erratum: Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/b-catenin function (Journal of Agricultural and Food Chemistry (2012) 60:28 (7031-7039) (DOI: 10.1021/jf301981n));Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt/β-catenin function

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 28, 2012, Pages 7031-7039

  Lin, Li Ching ^a,b   Yeh, Chi Tai ^c,d   Kuo, Chia Chun ^e   Lee, Chi Ming ^e   Yen, Gow Chin ^f   Wang, Liang Shun ^c,d   Wu, Chih Hsiung ^d   Yang, Wei Chung Vivian ^c   Wu, Alexander T H ^c,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

imatinib resistance; leukemia stem cells; reactive oxygen species; sulforaphane; catenin

Indexed keywords

ACTIVATION ANALYSIS; CELL CULTURE; CELL DEATH; DISEASES; ENZYME INHIBITION; FLOWCHARTING;

CANCER STEM CELLS; COMBINED TREATMENT; IMATINIB; LEUKEMIA STEM CELLS; PROTEIN EXPRESSIONS; REACTIVE OXYGEN SPECIES; REDUCED GLUTATHIONE; SULFORAPHANE;

STEM CELLS;

ANIMALIA;

EID: 84863924338     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf501087u     Document Type: Erratum

References (35)

1. Deininger, M. W.; Druker, B. J. Specific targeted therapy of chronic myelogenous leukemia with imatinib Pharmacol. Rev. 2003, 55, 401-423
2. Druker, B. J.; Guilhot, F.; O'Brien, S. G.; Gathmann, I.; Kantarjian, H.; Gattermann, N.; Deininger, M. W.; Silver, R. T.; Goldman, J. M.; Stone, R. M.; Cervantes, F.; Hochhaus, A.; Powell, B. L.; Gabrilove, J. L.; Rousselot, P.; Reiffers, J.; Cornelissen, J. J.; Hughes, T.; Agis, H.; Fischer, T.; Verhoef, G.; Shepherd, J.; Saglio, G.; Gratwohl, A.; Nielsen, J. L.; Radich, J. P.; Simonsson, B.; Taylor, K.; Baccarani, M.; So, C.; Letvak, L.; Larson, R. A. IRIS Investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N. Engl. J. Med. 2006, 355, 2408-2417
3. Gambacorti-Passerini, C. B.; Gunby, R. H.; Piazza, R.; Galietta, A.; Rostagno, R.; Scapozza, L. Molecular mechanisms of resistance to imatinib in Philadelphia-chromosome-positive leukaemias Lancet Oncol. 2003, 4, 75-85
4. Jiang, X.; Saw, K. M.; Eaves, A.; Eaves, C. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells J. Natl. Cancer Inst. 2007, 99, 680-693
5. Roche-Lestienne, C.; Soenen-Cornu, V.; Grardel-Duflos, N.; Lai, J. L.; Philippe, N.; Facon, T.; Fenaux, P.; Preudhomme, C. Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment Blood 2002, 100, 1014-1018
6. Shah, N. P.; Sawyers, C. L. Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias Oncogene 2003, 22, 7389-7395
7. Jiang, X.; Forrest, D.; Nicolini, F.; Turhan, A.; Guilhot, J.; Yip, C.; Holyoake, T.; Jorgensen, H.; Lambie, K.; Saw, K. M.; Pang, E.; Vukovic, R.; Lehn, P.; Ringrose, A.; Yu, M.; Brinkman, R. R.; Smith, C.; Eaves, A.; Eaves, C. Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate Blood 2010, 116, 2112-2121
8. Corbin, A. S.; Agarwal, A.; Loriaux, M.; Cortes, J.; Deininger, M. W.; Druker, B. J. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity J. Clin. Invest. 2011, 121, 396-409
9. Chen, Y.; Peng, C.; Li, D.; Li, S. Molecular and cellular bases of chronic myeloid leukemia Protein Cell 2010, 1, 124-132
10. Powolny, A. A.; Bommareddy, A.; Hahm, E. R.; Normolle, D. P.; Beumer, J. H.; Nelson, J. B.; Singh, S. V. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer J Natl. Cancer Inst. 2011, 103, 571-584
11. Boddupalli, S.; Mein, J. R.; Lakkanna, S.; James, D. R. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and E. Front Genet. 2012, 3 (Jan 24), article 7.
12. Keum, Y. S. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications Ann. N.Y. Acad. Sci. 2011, 1229, 184-189
13. Yeh, C. T.; Yen, G. C. Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells Carcinogenesis 2005, 26, 2138-2148
14. Jakubíková, J.; Sedlák, J.; Bod'o, J.; Bao, Y. Effect of isothiocyanates on nuclear accumulation of NF-kappaB, Nrf2, and thioredoxin in caco-2 cells J. Agric. Food Chem. 2006, 54, 1656-1662
15. Shapiro, T. A.; Fahey, J. W.; Dinkova-Kostova, A. T.; Holtzclaw, W. D.; Stephenson, K. K.; Wade, K. L.; Ye, L.; Talalay, P. Safety, tolerance, and metabolism of broccoli sprout glucosinolates and isothiocyanates: a clinical phase I study Nutr. Cancer 2006, 55, 53-62
16. Minami, Y.; Stuart, S. A.; Ikawa, T.; Jiang, Y.; Banno, A.; Hunton, I. C.; Young, D. J.; Naoe, T.; Murre, C.; Jamieson, C. H.; Wang, J. Y. BCR-ABL-transformed GMP as myeloid leukemic stem cells Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 17967-17972
17. Jamieson, C. H.; Ailles, L. E.; Dylla, S. J.; Muijtjens, M.; Jones, C.; Zehnder, J. L.; Gotlib, J.; Li, K.; Manz, M. G.; Keating, A.; Sawyers, C. L.; Weissman, I. L. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML N. Engl. J. Med. 2004, 351, 657-667
18. Yeung, J.; Esposito, M. T.; Gandillet, A.; Zeisig, B. B.; Griessinger, E.; Bonnet, D.; So, C. W. beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells Cancer Cell 2010, 18, 606-618
19. Yasui, H.; Hideshima, T.; Ikeda, H.; Ocio, E. M.; Kiziltepe, T.; Vallet, S.; Okawa, Y.; Neri, P.; Sukhdeo, K.; Podar, K.; Chauhan, D.; Richardson, P. G.; Raje, N.; Carrasco, D. R.; Anderson, K. C. Novel etodolac analog SDX-308 (CEP-18082) induces cytotoxicity in multiple myeloma cells associated with inhibition of beta-catenin/TCF pathway Leukemia 2007, 21, 535-540
20. Fimognari, C.; Hrelia, P. Sulforaphane as a promising molecule for fighting cancer Mutat. Res. 2007, 635, 90-104
21. Cho, S. D.; Li, G.; Hu, H.; Jiang, C.; Kang, K. S.; Lee, Y. S.; Kim, S. H.; Lu, J. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells Nutr. Cancer 2005, 52, 213-224
22. + human hemopoietic cells from normal and chronic myeloid leukemia sources Stem Cells 2007, 25, 3111-3120
23. Hu, Y.; Swerdlow, S.; Duffy, T. M.; Weinmann, R.; Lee, F. Y.; Li, S. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 16870-16875
24. Gamet-Payrastre, L.; Li, P.; Lumeau, S.; Cassar, G.; Dupont, M. A.; Chevolleau, S.; Gasc, N.; Tulliez, J.; Tercé, F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells Cancer Res. 2000, 60, 1426-1433
25. Pledgie-Tracy, A.; Sobolewski, M. D.; Davidson, N. E. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines Mol. Cancer Ther. 2007, 6, 1013-1021
26. Sattler, M.; Verma, S.; Shrikhande, G.; Byrne, C. H.; Pride, Y. B.; Winkler, T.; Greenfield, E. A.; Salgia, R.; Griffin, J. D. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells J. Biol. Chem. 2000, 275, 24273-24278
27. Choi, W. Y.; Choi, B. T.; Lee, W. H.; Choi, Y. H. Sulforaphane generates reactive oxygen species leading to mitochondrial perturbation for apoptosis in human leukemia U937 cells Biomed. Pharmacother. 2008, 62, 637-644
28. Trachootham, D.; Zhou, Y.; Zhang, H.; Demizu, Y.; Chen, Z.; Pelicano, H.; Chiao, P. J.; Achanta, G.; Arlinghaus, R. B.; Liu, J.; Huang, P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate Cancer Cell 2006, 10, 241-252
29. Koptyra, M.; Falinski, R.; Nowicki, M. O.; Stoklosa, T.; Majsterek, I.; Nieborowska-Skorska, M.; Blasiak, J.; Skorski, T. BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance Blood 2006, 108, 319-327
30. Essers, M. A.; de Vries-Smits, L. M.; Barker, N.; Polderman, P. E.; Burgering, B. M.; Korswagen, H. C. Functional interaction between beta-catenin and FOXO in oxidative stress signaling Science 2005, 308, 1181-1184
31. Naughton, R.; Quiney, C.; Turner, S. D.; Cotter, T. G. Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway Leukemia 2009, 23, 1432-1440
32. Giera, S.; Braeuning, A.; Kohle, C.; Bursch, W.; Metzger, U.; Buchmann, A.; Schwarz, M. Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver Toxicol. Sci. 2010, 115, 22-33
33. Wrobel, T.; Mazur, G.; Dziegiel, P.; Surowiak, P.; Kuliczkowski, K.; Zabel, M. Expression of metallothionein (MT) and gluthatione s-transferase pi (SGTP) in the bone marrow of patients with myeloproliferative disorders (MPD) Folia Morphol. (Warsaw) 2004, 63, 129-131
34. McWalter, G. K.; Higgins, L. G.; McLellan, L. I.; Henderson, C. J.; Song, L.; Thornalley, P. J.; Itoh, K.; Yamamoto, M.; Hayes, J. D. Transcription factor Nrf2 is essential for induction of NAD(P)H:quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteine ligase by broccoli seeds and isothiocyanates J. Nutr. 2004, 134, 3499S-3506S
35. Palmberg, E.; Johnsen, J. I.; Paulsson, J.; Gleissman, H.; Wickström, M.; Edgren, M.; Ostman, A.; Kogner, P.; Lindskog, M. Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo Int. J. Cancer 2009, 124, 1227-1234